Cargando…

Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies

Over 90% of potential anti-cancer drug candidates results in translational failures in clinical trials. The main reason for this failure can be attributed to the non-accurate pre-clinical models that are being currently used for drug development and in personalised therapies. To ensure that the asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Law, Andrew M. K., Rodriguez de la Fuente, Laura, Grundy, Thomas J., Fang, Guocheng, Valdes-Mora, Fatima, Gallego-Ortega, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669727/ https://www.ncbi.nlm.nih.gov/pubmed/34917509 http://dx.doi.org/10.3389/fonc.2021.782766

Ejemplares similares

Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancer
por: Rodriguez de la Fuente, Laura, et al.
Publicado: (2021)

Mammary Tumor Organoid Culture in Non‐Adhesive Alginate for Luminal Mechanics and High‐Throughput Drug Screening
por: Fang, Guocheng, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020)

Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research
por: Salinas-Vera, Yarely M., et al.
Publicado: (2022)

Advances of Patient-Derived Organoids in Personalized Radiotherapy
por: Wang, Yuenan, et al.
Publicado: (2022)

Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
por: Valdes-Mora, Fatima, et al.
Publicado: (2018)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
por: Tang, Lin, et al.
Publicado: (2021)

Research Advances on Anti-Cancer Natural Products
por: Guo, Meng, et al.
Publicado: (2022)

Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure
por: Chiloiro, Giuditta, et al.
Publicado: (2020)

Optimizing culturing conditions in patient derived 3D primary slice cultures of head and neck cancer
por: Greier, Maria do Carmo, et al.
Publicado: (2023)

Advanced Nano-Carriers for Anti-Tumor Drug Loading
por: Xiang, Jia, et al.
Publicado: (2021)

Advances in Personalized Targeted Treatment of Metastatic Melanoma and Non-Invasive Tumor Monitoring
por: Klinac, Dragana, et al.
Publicado: (2013)

Effectiveness of PARP inhibition in enhancing the radiosensitivity of 3D spheroids of head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2022)

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures
por: Kloskowski, Tomasz, et al.
Publicado: (2023)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Advances in Stigmasterol on its anti-tumor effect and mechanism of action
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
por: Filimonova, Irina, et al.
Publicado: (2021)

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
por: Geevimaan, Khamushavalli, et al.
Publicado: (2022)

Anti-N-methyl-D-aspartate Encephalitis Concomitantly with Tall-cell Variant Papillary Thyroid Carcinoma
por: Mahadeen, Ahmad, et al.
Publicado: (2019)

Peptide Hydrogels – Versatile Matrices for 3D Cell Culture in Cancer Medicine
por: Worthington, Peter, et al.
Publicado: (2015)

Current Advances in Mathematical Modeling of Anti-Cancer Drug Penetration into Tumor Tissues
por: Kim, MunJu, et al.
Publicado: (2013)

Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models
por: Kim, Jiyun, et al.
Publicado: (2015)

Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization
por: Sukphokkit, Siriwat, et al.
Publicado: (2023)

ALTEN: A High‐Fidelity Primary Tissue‐Engineering Platform to Assess Cellular Responses Ex Vivo
por: Law, Andrew M. K., et al.
Publicado: (2022)

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
por: Varnier, Romain, et al.
Publicado: (2021)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
por: Knebel, Franciele H., et al.
Publicado: (2019)

Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer
por: Wang, Yue, et al.
Publicado: (2021)

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
por: Xiao, Mingshu, et al.
Publicado: (2022)

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma
por: Stoff, Ronen, et al.
Publicado: (2023)

NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2022)

LncRNA APTR Promotes Uterine Leiomyoma Cell Proliferation by Targeting ERα to Activate the Wnt/β-Catenin Pathway
por: Zhou, Weiqiang, et al.
Publicado: (2021)

Circulating Tumor Cells: The Substrate of Personalized Medicine?
por: Greene, Bryan T., et al.
Publicado: (2012)

Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
por: Ryan, Éanna J., et al.
Publicado: (2020)

Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
por: Benitez Fuentes, Javier David, et al.
Publicado: (2022)

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
por: Fleuren, Emmy D. G., et al.
Publicado: (2023)

Are We Making Personalized Cancer Care Less Personalized?
por: Sorscher, Steven
Publicado: (2016)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
por: Adham, Sirin A., et al.
Publicado: (2022)

Editorial: Intraoperative Radiotherapy (IORT)—A New Frontier for Personalized Medicine as Adjuvant Treatment and Treatment of Locally Recurrent Advanced Malignancy
por: Thomas, Tarita O., et al.
Publicado: (2018)

Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study
por: Wang, Peiliang, et al.
Publicado: (2021)

Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
por: Ma, Ji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nd1l4g66s4201i4v6dd13plirt